Key terms
About CNSP
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CNSP news
Apr 15
6:22am ET
CNS Pharmaceuticals Conducts Informational Investor Meetings
Feb 27
5:33pm ET
CNS Pharmaceuticals Strives to Regain Nasdaq Compliance
Jan 29
9:33pm ET
CNS Pharmaceuticals prices $4.0M public offering at 30c per share
Jan 18
8:47am ET
CNS Pharmaceuticals appoints Amy Mahery to board of directors
Jan 17
8:52am ET
CNS Pharmaceuticals completes planned enrollment in study of berubicin in GBM
No recent press releases are available for CNSP
CNSP Financials
Key terms
Ad Feedback
CNSP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CNSP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
